Nucl Med Mol Imaging.
2013 Sep;47(3):201-204.
An Unusual Case of Anaphylaxis After Fluorine-18-Labeled Fluorodeoxyglucose Injection
- Affiliations
-
- 1Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. jjwalking@amc.seoul.kr
- 2Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Abstract
- [18F]FDG (fluorine-18 fluoro-2-deoxy-D-glucose) positron emission tomography (PET) is used worldwide for oncologic and neurologic applications. To date, the potential harm caused by [18F]FDG has focused on its radiation exposure effects rather than on its pharmacological effects. While an allergic response in the form of a skin manifestation has been reported after exposure to [18F]FDG, this report describes the first case of hypotension following exposure to this tracer. Here, the development of anaphylaxis after [18F]FDG injection is described.